Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07774494
Starting soon Not applicable

Effect of AI-Assisted Discharge Education on Parents of Children With Bronchitis/Bronchiolitis

NCT07774494 · tracked via the Priya Life Science Turkey tracker
Sponsor
Osmaniye Korkut Ata University
Phase
Not applicable
Started
2026-10-15
Last updated
2026-08-20

Condition(s) studied

BronchiolitisBronchitis

Investigational drug(s) / intervention(s)

AI-Assisted Written Discharge EducationAI-Assisted Video Discharge EducationRoutine Discharge Education

AI-Assisted Written Discharge Education: A written discharge education booklet developed with support from ChatGPT based on standard discharge content and expert review.

AI-Assisted Video Discharge Education: A video discharge education intervention developed with support from Gemini Notebook and designed to cover the same learning objectives as the written material.

Routine Discharge Education: Standard discharge education routinely provided by the institution.

Study summary

This randomized controlled trial aims to evaluate the effects of artificial intelligence-assisted discharge education on mothers of children hospitalized with bronchitis/bronchiolitis. A total of 162 mothers will be randomly assigned to one of three groups: AI-assisted written discharge education, AI-assisted video discharge education, or routine discharge education. The primary outcome will be mothers' knowledge of home care after discharge. Secondary outcomes will include anxiety, readiness for hospital discharge, and satisfaction with discharge education. The study hypothesizes that AI-assisted written and video discharge education will improve mothers' knowledge and readiness for discharge, reduce anxiety, and increase satisfaction compared with routine discharge education.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Mother of a child hospitalized with a diagnosis of bronchitis/bronchiolitis * Child hospitalized for at least 3 days * Willing to participate and provide informed consent * Able to read and understand Turkish and communicate sufficiently to complete the study forms * Owns a smartphone Exclusion Criteria: * Unable to read/view the educational materials or complete the study forms * Child requiring intensive care, experiencing severe clinical deterioration, or having a condition preventing completion of the study * Child with an additional chronic disease or special care needs * Mother who is a healthcare professional

Primary outcome measure(s)

  • Change in Maternal Knowledge Score Regarding Home Care After Discharge — Baseline before randomization and at hospital discharge, during the same hospitalization.
    Maternal knowledge will be assessed using a 10-item true/false knowledge test developed according to the content of the discharge education. Each correct answer is scored as 1 and each incorrect answer as 0, yielding a total score ranging from 0 to 10. Higher scores indicate greater knowledge.

Trial sites (1)

FacilityCityRegionStatus
Osmaniye Training and Research Hospital Osmaniye Osmaniye

More Osmaniye Korkut Ata University trials in Turkey

Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea Recruiting
The Effect of Virtual Reality-Based Intervention on Anxiety, Stress, and Pain in Women Undergoing Colposcopy: A Randomized Controlled Trial Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07774494 on ClinicalTrials.gov ↗ ← All trials in Turkey